U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Advanced Breast Carcinoma

MedGen UID:
1687643
•Concept ID:
C5206719
•
Neoplastic Process

Definition

Breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. [from NCI]

Professional guidelines

PubMed

A comparison of combination chemotherapy using vindesine or vincristine with adriamycin in the treatment of advanced breast carcinoma.
Smith IE, Hedley DW, Coombes RC, Powles TJ
Cancer Treat Rev 1980 Sep;7 Suppl 1:71-3. doi: 10.1016/s0305-7372(80)80011-9. PMID: 7438125
Treatment for advanced breast carcinoma.
Gribbons CA, Aliapoulios MA
Am J Nurs 1972 Apr;72(4):678-82. PMID: 4481941
Treatment of advanced breast carcinoma with drostanolone propionate. A case report.
Heney NM
Bristol Med Chir J 1970 Jul;85(315):75-6. PMID: 5536155Free PMC Article

Recent clinical studies

Etiology

Surgical management of locally advanced breast cancer: Recommendations of the Brazilian Society of Surgical Oncology.
da Costa Vieira RA, Andrade WP, Vieira SC, Romano M, Iglesias G, Oliveira AF
J Surg Oncol 2022 Jul;126(1):57-67. doi: 10.1002/jso.26890. PMID: 35689588
Megestrol acetate in advanced breast carcinoma.
Espie M
Oncology 1994 Oct;51 Suppl 1:8-12. doi: 10.1159/000227408. PMID: 7970508
Monoclonal antibody NCRC 11 reactivity with advanced breast carcinoma: lack of prognostic value.
Arnerlöv C, Ellis IO, Emdin SO
Histopathology 1988 Dec;13(6):695-7. doi: 10.1111/j.1365-2559.1988.tb02100.x. PMID: 2853132
Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW, Weiss RB, Korzun AH, Wood WC, Carey RW, Panasci LC
Cancer Treat Rep 1985 Jul-Aug;69(7-8):919-20. PMID: 3893695
Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.
Gottlieb JA, Rivkin SE, Spigel SC, Hoogstraten B, O'Bryan RM, Delaney FC, Singhakowinta A
Cancer 1974 Feb;33(2):519-26. doi: 10.1002/1097-0142(197402)33:2<519::aid-cncr2820330229>3.0.co;2-x. PMID: 4812769

Diagnosis

Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding.
Haynes HR, Mohan V, Mozayani B, Gallagher P
Breast J 2021 Jul;27(7):612-614. Epub 2021 May 14 doi: 10.1111/tbj.14238. PMID: 33987967
Giant sclerosing papilloma mimicking locally advanced breast carcinoma.
Vieira RA, Sabino SM, Matthes GZ, Watanabe AH, Abrahao-Machado LF
Rev Assoc Med Bras (1992) 2014 Nov-Dec;60(6):518-9. doi: 10.1590/1806-9282.60.06.007. PMID: 25650849
Tissue factor as a novel marker for detection of circulating cancer cells.
Otero LL, Alonso DF, Castro M, Cinat G, Gabri MR, Gomez DE
Biomarkers 2011 Feb;16(1):58-64. Epub 2010 Dec 6 doi: 10.3109/1354750X.2010.533282. PMID: 21128872
Dynamic imaging: scintimammography.
Salvatore M, Del Vecchio S
Eur J Radiol 1998 May;27 Suppl 2:S259-64. doi: 10.1016/s0720-048x(98)00072-2. PMID: 9652532
Patterns and prognosis of advanced breast carcinoma.
Donegan WL
Mo Med 1970 Dec;67(12):853-8. PMID: 5495896

Therapy

Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding.
Haynes HR, Mohan V, Mozayani B, Gallagher P
Breast J 2021 Jul;27(7):612-614. Epub 2021 May 14 doi: 10.1111/tbj.14238. PMID: 33987967
Hormone therapy in advanced breast carcinoma: present and future trends.
Bajetta E, Zilembo N, Di Leo A, Buzzoni R, Zampino MG, Biganzoli L, Noberasco C
Cancer Treat Rev 1994 Jul;20(3):241-58. doi: 10.1016/0305-7372(94)90002-7. PMID: 8020005
Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW, Weiss RB, Korzun AH, Wood WC, Carey RW, Panasci LC
Cancer Treat Rep 1985 Jul-Aug;69(7-8):919-20. PMID: 3893695
Treatment of advanced breast carcinoma with drostanolone propionate. A case report.
Heney NM
Bristol Med Chir J 1970 Jul;85(315):75-6. PMID: 5536155Free PMC Article
Hormone therapy in advanced breast carcinoma.
FOSS GL
Proc R Soc Med 1955 Jul;48(7):551-3. PMID: 13245829

Prognosis

Tissue factor as a novel marker for detection of circulating cancer cells.
Otero LL, Alonso DF, Castro M, Cinat G, Gabri MR, Gomez DE
Biomarkers 2011 Feb;16(1):58-64. Epub 2010 Dec 6 doi: 10.3109/1354750X.2010.533282. PMID: 21128872
Dynamic imaging: scintimammography.
Salvatore M, Del Vecchio S
Eur J Radiol 1998 May;27 Suppl 2:S259-64. doi: 10.1016/s0720-048x(98)00072-2. PMID: 9652532
Monoclonal antibody NCRC 11 reactivity with advanced breast carcinoma: lack of prognostic value.
Arnerlöv C, Ellis IO, Emdin SO
Histopathology 1988 Dec;13(6):695-7. doi: 10.1111/j.1365-2559.1988.tb02100.x. PMID: 2853132
Predictability of response to endocrine ablation in advanced breast carcinoma. A correlation to estrogen receptor and steroid sulfurylation.
Leung BS, Fletcher WS, Lindell TD, Wood DC, Krippaechne WW
Arch Surg 1973 Apr;106(4):515-9. doi: 10.1001/archsurg.1973.01350160129021. PMID: 4348827
Patterns and prognosis of advanced breast carcinoma.
Donegan WL
Mo Med 1970 Dec;67(12):853-8. PMID: 5495896

Clinical prediction guides

Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
Denis F, Desbiez-Bourcier AV, Chapiron C, Arbion F, Body G, Brunereau L
Eur J Surg Oncol 2004 Dec;30(10):1069-76. doi: 10.1016/j.ejso.2004.07.024. PMID: 15522553
Dynamic imaging: scintimammography.
Salvatore M, Del Vecchio S
Eur J Radiol 1998 May;27 Suppl 2:S259-64. doi: 10.1016/s0720-048x(98)00072-2. PMID: 9652532
Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
Brufman G, Isacson R, Haim N, Gez E, Sulkes A
Oncology 1994 May-Jun;51(3):258-61. doi: 10.1159/000227345. PMID: 8196908
Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen.
Beretta G, Locatelli C, Tabiadon D, Labianca R, Fraschini P, Luporini G
Oncology 1987;44(1):6-12. doi: 10.1159/000226434. PMID: 2436124
Predictability of response to endocrine ablation in advanced breast carcinoma. A correlation to estrogen receptor and steroid sulfurylation.
Leung BS, Fletcher WS, Lindell TD, Wood DC, Krippaechne WW
Arch Surg 1973 Apr;106(4):515-9. doi: 10.1001/archsurg.1973.01350160129021. PMID: 4348827

Recent systematic reviews

The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review.
Deitcher SR, Gomes MP
Cancer 2004 Aug 1;101(3):439-49. doi: 10.1002/cncr.20347. PMID: 15274057

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...